Programme Coordinator, Iwona Czerwinskam, and Senior Lecturer, Katie Shaw, reflect on the IMPALA Global Meeting in Kigali, Rwanda, September 2026. by Iwona Czerwinskam | Programme Coordinator and Katie Shaw | Senior LecturerIn September 2026, Kigali welcomed 150 delegates for the annual I3P IMPALA Investigators’ Meeting, bringing together colleagues from across an international research partnership that has grown and evolved over the past decade. For many, it also brought back memories of the NIHR Global Surgery Unit Research Prioritisation Workshop held in Kigali in 2018. Eight years on, the meeting demonstrated the value of sustained partnerships built on mutual trust, shared learning, and a common commitment to improving maternal and neonatal health. Following two previous IMPALA annual meetings hosted in Edinburgh, the meeting provided an opportunity to share progress, strengthen existing relationships and plan the next stages of our collaborative research.Bringing the global research community togetherThe Intrapartum Monitoring Platform: leAding chiLdbirth sAfety programme, known as IMPALA, is being led by a team from the Centre for Medical Informatics and the Centre for Reproductive Health. Principal Investigators (PI), Dr Rosemary Townsend, Senior Lecturer and Honorary Consultant in Obstetrics, Centre for Reproductive Health and affiliate member of the Usher Institute, Professor Ewen Harrison (Professor of Surgery and Data Science) and Dr Katie Shaw (Senior Lecturer and Programme Manager) lead a team of data scientists, qualitative researchers, and project managers to co-ordinate this international effort. Through collaboration with international partners across clinical, scientific and technological disciplines, the programme aims to ensure that research and innovation respond to the needs of healthcare professionals and the communities they serve.Maternal and newborn health remain major global challenges, requiring collaboration across disciplines, institutions and healthcare systems. The IMPALA research programme aims to improve outcomes for mothers and babies through innovative approaches to maternal and fetal monitoring. By exploring continuous monitoring technologies and machine-learning approaches, the programme seeks to support earlier detection of complications during labour and childbirth, helping clinicians make better-informed decisions. At the heart of this work lies a shared commitment: No mother should die while giving life, and no child should die or suffer lifelong disability.Two days in KigaliThe meeting focused on sharing the results from the IMPALA 1 study - establishing the feasibility and acceptability of continuous intrapartum monitoring in resource-limited settings – and preparing for the next stage of the programme: IMPALA 2. IMPALA 2 is a large-scale cluster randomised trial designed to test whether continuous intrapartum monitoring reduces severe maternal and neonatal outcomes, including death. Beginning in early 2027, the trial will be conducted in 4 partner countries (India, Nigeria, Rwanda and Pakistan) and aims to recruit 13,000 women from 30 hospitals. Through presentations, focused discussions and collaborative workshops, delegates reviewed research progress, exchanged experiences and identified priorities for the launch of IMPALA 2.Held at the Kigali Conference and Exhibition Village, the two-day meeting brought together a truly international research community from across the world, including representatives from the UK, Nigeria, India, Kenya, Pakistan, the United States and Rwanda. Researchers, clinicians, engineers and other partners came together to discuss research priorities, share progress and explore opportunities to maximise the impact of the IMPALA research programme The agenda also included parallel information sessions and introductory Train-the-Trainer sessions, giving participants opportunities to share expertise, develop their knowledge and prepare for future programme activities. These sessions encouraged the exchange of ideas and helped partners consider how research findings, training and innovation could be taken forward collaboratively.Looking aheadAs the I3P Global Meeting came to a close, its value extended beyond the presentations, workshops and discussions themselves. The research progress shared, priorities identified and relationships strengthened will help shape the next stages of IMPALA and the wider collaborative effort. Looking ahead, IMPALA 2 marks an exciting new chapter: building on the foundations established so far, this next phase represents a significant step towards generating robust evidence and advancing the project's impact on women's health.Our time in Kigali reaffirmed that meaningful progress depends not only on what we research, but also on how we work together. By continuing to share expertise, learn from different healthcare systems and build lasting, equitable partnerships, we can move closer to a future in which preventable maternal and newborn deaths and lifelong disabilities become increasingly rare.Ultimately, our ambition remains clear: to strengthen global collaboration and translate research and innovation into better outcomes for mothers and children everywhere.Further informationIMPALA – Global Surgery Research UK Team members Usher's Centre for Medical Informatics:Professor Ewen Harrison, Principal InvestigatorDr Katie Shaw, Senior Lecturer & Principal InvestigatorDr Neil Clark, Data AnalystMr Malcolm Cameron, Research AssistantDr Eilidh Gunn, Project ManagerDr Theresa Ikegwuonu, Qualitative Research LeadMs Laura Bellussi, Research Fellow in Social ScientistMs Iwona Czerwinska, Programme Co-ordinator Usher's Centre for Reproductive Health: Dr Rosemary Townsend, Senior Research Fellow & Principal InvestigatorDr Jenny Riches, Clinical Lecturer Dr Tom Mitchell, Clinical Research FellowUK collaborating partner University of Birmingham: Dr Soha Sobhy, Obstetric ConsultantDr Sam Watson, Project StatisticianDr Audgrey Nganwa, Programme ManagerMr Michael Bahrami-Hessari, Community Engagement & Involvement Lead This article was published on Wednesday 18 November 2026